The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 513.50
Bid: 510.00
Ask: 511.00
Change: 5.50 (1.08%)
Spread: 1.00 (0.196%)
Open: 510.00
High: 513.50
Low: 503.00
Prev. Close: 508.00
DRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

28 Jun 2019 12:00

RNS Number : 8484D
Drax Group PLC
28 June 2019
 

28 June 2019

 

Drax Group plc

(Symbol: DRX)

Retirement of Non-Executive Director

Drax Group plc today confirms that, as previously announced on 21 February 2019, Tony Thorne, a non-executive director who joined the Board in June 2010, will be standing down from the Board on 28 June 2019, having served nine years.

In accordance with section 430(2B) of the Companies Act 2006, details of payments made to and receivable by Mr Thorne during 2019 will shortly be available on the Drax website. Full details of all payments made to and receivable by Mr Thorne will be disclosed in the Remuneration Report within the Company's Annual Report and Accounts for the year ended 31 December 2019.

- - ENDS - -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOACKFDPKBKDDAB
Date   Source Headline
24th Apr 20243:33 pmRNSHolding(s) in Company
23rd Apr 202410:34 amRNSHolding(s) in Company
19th Apr 202410:32 amRNSNotice of Redemption
18th Apr 20245:01 pmRNSPricing of offering of Senior Secured Notes
17th Apr 20249:00 amRNSDirector/PDMR Shareholding
16th Apr 202410:54 amRNSFixed income investor calls
15th Apr 20249:35 amRNSHolding(s) in Company
8th Apr 20244:54 pmRNSHolding(s) in Company
5th Apr 20243:48 pmRNSBlock listing Interim Review
5th Apr 20243:47 pmRNSBlock listing Interim Review
5th Apr 20243:42 pmRNSBlock listing Interim Review
5th Apr 20248:00 amRNSDirector/PDMR Shareholding
4th Apr 20245:11 pmRNSHolding(s) in Company
4th Apr 202410:18 amRNSTotal Voting Rights
4th Apr 20247:00 amRNSNew £150 million term-loan facility
3rd Apr 202410:15 amRNSHolding(s) in Company
28th Mar 20243:05 pmRNSHolding(s) in Company
25th Mar 20243:48 pmRNSHolding(s) in Company
25th Mar 20248:45 amRNSAdditional Listing
22nd Mar 202410:54 amRNSHolding(s) in Company
21st Mar 20248:00 amRNSMailing of Annual Report and Notice of AGM
18th Mar 20242:04 pmRNSHolding(s) in Company
18th Mar 202410:30 amRNSDirector/PDMR Shareholding
15th Mar 20242:51 pmRNSHolding(s) in Company
14th Mar 20241:37 pmRNSHolding(s) in Company
11th Mar 202412:26 pmRNSHolding(s) in Company
8th Mar 20244:07 pmRNSHolding(s) in Company
6th Mar 20242:46 pmRNSHolding(s) in Company
4th Mar 20243:35 pmRNSTotal Voting Rights
4th Mar 20243:18 pmRNSHolding(s) in Company
1st Mar 20242:38 pmRNSHolding(s) in Company
29th Feb 20247:04 amRNSNon-Executive Director standing down
29th Feb 20247:00 amRNSAnnual Financial Report
28th Feb 20247:00 amRNSCapacity Market Agreements
27th Feb 20249:20 amRNSHolding(s) in Company
23rd Feb 20244:32 pmRNSHolding(s) in Company
22nd Feb 202412:46 pmRNSNotice of Results
21st Feb 20249:32 amRNSHolding(s) in Company
15th Feb 202410:51 amRNSHolding(s) in Company
13th Feb 202412:47 pmRNSHolding(s) in Company
7th Feb 202410:32 amRNSHolding(s) in Company
1st Feb 202411:56 amRNSTotal Voting Rights
31st Jan 20243:16 pmRNSHolding(s) in Company
30th Jan 20242:15 pmRNSHolding(s) in Company
30th Jan 20248:45 amRNSAdditional Listing
29th Jan 20243:02 pmRNSHolding(s) in Company
25th Jan 20249:37 amRNSHolding(s) in Company
23rd Jan 20243:43 pmRNSHolding(s) in Company
18th Jan 202411:54 amRNSBridging Mechanism Consultation
16th Jan 20249:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.